# Hydrochlorothiazide and Risk of Skin Cancer

> **NCT04334824** · — · COMPLETED · sponsor: **Canadian Network for Observational Drug Effect Studies, CNODES** · enrollment: 2953748 (actual)

## Conditions studied

- Non-melanoma Skin Cancer
- Melanoma
- Hypertension

## Interventions

- **DRUG:** Hydrochlorothiazide
- **DRUG:** Angiotensin-converting enzyme (ACE) inhibitors

## Key facts

- **NCT ID:** NCT04334824
- **Lead sponsor:** Canadian Network for Observational Drug Effect Studies, CNODES
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-27
- **Primary completion:** 2021-03-05
- **Final completion:** 2021-03-05
- **Target enrollment:** 2953748 (ACTUAL)
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04334824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04334824, "Hydrochlorothiazide and Risk of Skin Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04334824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*